Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Serendex Pharmaceuticals

2008 FOUNDED
M&A STATUS
11-20 EMPLOYEES
Asset Purch. LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Pharmaceutical and respiratory drugs. The products can be used to treat autoimmune pulmonary alveolar proteinosis and diffuse alveolar hemorrhage.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Slotsmarken 17, 2. tv
  • 2970 Hørsholm
  • Denmark

+45 79 00 00 00

Serendex Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Serendex Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Serendex Pharmaceuticals Board Members (1)

Name Representing Role Since Contact
Info
00000 00000000 Self Board Member 000 0000